# Elira

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/elira

- Industry: Medical Devices & Equipment
- Headquarters: St. Louis, US
- Website: www.elira.com
- Total disclosed funding: $2.5M
- Latest round: Series B (Oct 1, 2020)
- Investors on record: 1

## About

Based in Missouri, US, and founded in 2015 by Raul Perez, Elira Inc., formerly known as Elira Therapeutics, is a developer and provider of a wearable patch, intended to help overweight adults suppress their appetite effectively and thereby reduce weight. In October 2020, Elira Inc. raised USD 2.5 million in series B from new investor Solas BioVentures.

The company offers ELIRA-2, a drug-free, wearable patch TENS (Transcutaneous Nerve Stimulator) system that uses neurostimulation techniques to help overweight people better control their eating habits by suppressing appetite in a safe way, enabling them to lose weight and achieve their health and fitness goals.

## Funding rounds

- Series B, Oct 1, 2020, $2.5M — Solas BioVentures

## Investors

- Solas BioVentures (https://capitalatlas.ai/funds/solas-bioventures) — Series B